跳至主要内容
临床试验/NCT03659786
NCT03659786Unknown不适用

Cumulus Cell Messenger Ribonucleic Acid (mRNA) Analysis as Oocyte Quality Marker in the Fertility Lab in a Prospective Single-center Study

Universitair Ziekenhuis Brussel2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Clinical pregnancy as observed by ultrasound

研究概览

简要总结

Performing an additional non-invasive oocyte diagnostic test based on cumulus cell gene expression could improve the outcome of the ART cycle

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
— 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • scheduled for intracytoplasmatic sperm injection (ICSI) and single or double embryo transfer on day 3
  • patients down regulated with gonadotropin-releasing hormone (GnRH) antagonist and stimulated with Highly Purified human Menopausal Gonadotropin (HP-hMG)
  • undergoing first or second IVF or ICSI cycle with transfer
  • Body Mass Index (BMI) between 17 and
  • regular menstrual cycle (between 24 and 35 days)

排除标准

  • smokers (> 10 cigarettes per day)
  • patients requesting Pre-implantation Genetic Diagnosis (PGD)
  • patients with polycystic ovary syndrome (PCOS), or severe endometriosis (AFS stage 3-4)
  • couples where the partner has an extremely low sperm count e.g.: extreme oligo-astheno-teratozoospermia (OAT) (< 100.000/ml) or scheduled for testicular sperm extraction (TESE)
  • results of eventual preceding cycles may not indicate a known genetic disease, or low ovarian response or an oocyte maturation defect

研究组 & 干预措施

Day 3 transfer control group

No Intervention

Patients undergo the standard ART treatment, as prescribed by the treating physician, with standard morphology based scoring of the embryos and transfer of the best embryo based on day 3 of embryo growth (cleavage stage embryo)

CC-Test diagnosis and Day 3 transfer

Experimental

Patients undergo the standard ART treatment, as prescribed by the treating physician, with standard morphology based scoring of the embryos + the extra cumulus cell based diagnosis and transfer of the best embryo based on morphology and CC diagnosis on day 3 of embryo growth (cleavage stage embryo)

干预措施: CC-Test (Other)

Day 5 transfer control group

No Intervention

Patients undergo the standard ART treatment, as prescribed by the treating physician, with standard morphology based scoring of the embryos and transfer of the best embryo based on day 5 of embryo growth (blastocyst stage embryo)

结局指标

主要结局

Clinical pregnancy as observed by ultrasound

时间窗: 2 months after embryo transfer

This observation is routinely performed by the treating physician for every patient undergoing standard ART treatment and is thus available from the fertility center database

次要结局

  • Live birth by questionnaire(at least 9 months after embryo transfer)
  • Cumulative pregnancy(2 years after embryo transfer)
  • Positive beta-hCG Pregnancy as observed by serum analysis(12-17 days after embryo transfer)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Single-center Prospective Cumulus Cell Test Study | 临床试验